Group
MedTech Long
20 themes125 tickers
10D rank#13of 142 groups
Curious about healthcare's future? MedTech Long dives into medical devices, advanced diagnostics, and cutting-edge therapies. We track innovation, an aging population, and policy shifts driving growth across AI platforms, regenerative medicine, and beyond.
MedTech Long '24: Lab & Life Sciences Tools+30.47%5.0%
MedTech Long '24: Lab Research & Trials+69.90%5.0%
MedTech Long '24: Medical Devices-1.95%5.0%
MedTech Long '24: Regenerative Med+18.34%5.0%
MedTech Long '24: Trump-Favorable Regs-2.17%5.0%
MedTech Long '25 : US Drug Dev Outsourcing+52.82%5.0%
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med+42.22%5.0%
MedTech Long '25: Aging-Driven Procedures & Care+21.36%5.0%
MedTech Long '25: Cancer Diagnostics, Platforms & Care+109.82%5.0%
MedTech Long '25: Centralized Lab Diagnostics+120.46%5.0%
MedTech Long '25: Consumer Platforms-6.52%5.0%
MedTech Long '25: Diagnostic Platforms+52.19%5.0%
MedTech Long '25: Elective Aesthetics+10.96%5.0%
MedTech Long '25: HC Data & Services+41.63%5.0%
MedTech Long '25: Mental Health+97.97%5.0%
MedTech Long '25: Neuromodulation & Neurotechnology Devices+44.18%5.0%
MedTech Long '25: Wearable Health+24.13%5.0%
MedTech Long '26: CROs+50.01%5.0%
MedTech Long '26: Diagnostics & Early Detection+89.20%5.0%
MedTech Long '26: Life Science Tools & Bioprocessing+37.74%5.0%
As of Aug 24, 2026, 4:48 AM ET
Themes in this group
Build 20260824T084825
| MedTech Long '25: Diagnostic Platforms | 7 | $5.32B | $37.22B | +2.83% | +12.75% | +8.75% | +8.82% | +17.64% | +52.19% | +35.09% | -52.76% | +22.92% | +46.73% | +12.35% | +69.03% | +4.09% | +8.52% |
| MedTech Long '24: Lab Research & Trials | 7 | $10.55B | $73.82B | +1.28% | +7.83% | +13.52% | +9.06% | +39.35% | +69.90% | +37.04% | +1.18% | +27.45% | +46.81% | +40.66% | +88.43% | +5.68% | +8.54% |
| MedTech Long '26: Life Science Tools & Bioprocessing | 14 | $45.53B | $637.46B | +0.68% | +7.02% | +14.50% | +9.36% | +19.30% | +37.74% | +13.90% | -15.14% | +26.84% | +40.95% | +31.19% | +41.85% | +0.65% | +12.96% |
| MedTech Long '25: Cancer Diagnostics, Platforms & Care | 10 | $5.79B | $57.90B | +2.15% | +6.80% | +15.30% | +15.99% | +44.90% | +109.82% | +264.03% | +64.42% | +26.59% | +53.95% | +44.39% | +179.24% | +5.84% | +5.02% |
| MedTech Long '25: Centralized Lab Diagnostics | 4 | $11.63B | $46.54B | +1.37% | +6.44% | +20.88% | +22.63% | +36.24% | +120.46% | +387.89% | +195.21% | +35.27% | +82.36% | +66.59% | +235.20% | +5.35% | +5.11% |
| MedTech Long '26: Diagnostics & Early Detection | 16 | $29.08B | $465.33B | +2.05% | +5.51% | +12.00% | +13.29% | +27.83% | +89.20% | +108.84% | +91.60% | +28.27% | +47.68% | +34.85% | +116.81% | +9.19% | +11.75% |
| MedTech Long '25: Wearable Health | 17 | $17.68B | $282.82B | +0.70% | +5.23% | +24.47% | +18.75% | +20.85% | +24.13% | +26.61% | -6.55% | +28.13% | +26.71% | +10.11% | +15.45% | +10.25% | +13.28% |
| MedTech Long '24: Trump-Favorable Regs | 8 | $8.58B | $68.62B | +1.76% | +4.32% | +6.23% | +3.32% | +1.44% | -2.17% | -25.67% | -43.70% | +10.63% | -6.20% | +5.70% | +1.60% | +5.76% | +8.24% |
| MedTech Long '25 : US Drug Dev Outsourcing | 8 | $3.65B | $29.23B | +1.01% | +3.34% | +16.57% | +10.76% | +34.24% | +52.82% | +29.49% | -10.93% | +30.55% | +61.35% | +60.69% | +61.82% | +10.05% | +6.45% |
| MedTech Long '24: Lab & Life Sciences Tools | 10 | $51.68B | $516.80B | +1.11% | +3.33% | +14.54% | +7.33% | +11.16% | +30.47% | -1.98% | -24.71% | +25.00% | +39.42% | +25.53% | +22.91% | +2.40% | +13.84% |
| MedTech Long '26: CROs | 7 | $50.10B | $350.68B | +0.69% | +3.33% | +17.66% | +8.92% | +19.06% | +50.01% | +15.29% | +29.41% | +37.98% | +61.35% | +48.90% | +70.77% | +8.19% | +8.58% |
| MedTech Long '25: Consumer Platforms | 5 | $4.08B | $20.40B | -0.71% | +2.52% | +0.83% | +1.38% | +4.12% | -6.52% | -1.43% | -36.97% | +13.91% | +37.81% | +45.01% | +8.87% | -2.65% | +12.18% |
| MedTech Long '24: Medical Devices | 8 | $25.42B | $203.34B | +0.63% | +2.45% | +6.42% | +4.81% | -12.09% | -1.95% | +7.86% | -0.39% | +11.42% | +0.38% | -3.73% | -14.25% | +6.73% | +11.51% |
| MedTech Long '25: Neuromodulation & Neurotechnology Devices | 9 | $670.0M | $6.03B | -0.13% | +2.38% | +16.42% | +13.31% | +24.22% | +44.18% | +94.58% | +109.26% | +26.87% | +16.73% | +27.60% | +29.35% | +4.28% | +8.95% |
| MedTech Long '24: Regenerative Med | 6 | $871.9M | $5.23B | +1.03% | +2.29% | +9.00% | +10.25% | -1.94% | +18.34% | +35.52% | +13.09% | +21.44% | +22.22% | +3.44% | +16.62% | -0.81% | -1.71% |
| MedTech Long '25: Aging-Driven Procedures & Care | 11 | $16.54B | $181.89B | +1.46% | +2.24% | +7.61% | +5.33% | +2.22% | +21.36% | +42.72% | +46.09% | +14.82% | +15.39% | +13.90% | +32.21% | -5.22% | +1.38% |
| MedTech Long '25: Adv Bio Therapeutics & Regenerative Med | 6 | $3.75B | $22.52B | -0.94% | +1.53% | +7.85% | +6.56% | +6.95% | +42.22% | +62.30% | +124.61% | +14.09% | +8.44% | -0.77% | +43.89% | +15.10% | +1.46% |
| MedTech Long '25: Mental Health | 8 | $3.20B | $25.57B | -0.89% | +0.23% | +5.77% | +7.74% | +78.04% | +97.97% | +290.80% | +190.06% | +28.41% | +39.50% | +77.32% | +165.09% | +3.08% | -2.24% |
| MedTech Long '25: HC Data & Services | 6 | $3.27B | $19.59B | -1.26% | -1.03% | +1.33% | +5.66% | +29.99% | +41.63% | +140.07% | +37.04% | +9.57% | +37.29% | +42.20% | +75.31% | -8.45% | -3.18% |
| MedTech Long '25: Elective Aesthetics | 8 | $753.8M | $6.03B | +1.54% | -2.53% | -9.75% | -8.09% | +9.85% | +10.96% | +25.77% | -40.80% | -4.55% | +10.99% | +21.64% | +41.85% | -4.83% | -3.77% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary